Overview

Pharmacokinetic Study of 48-hour Sevoflurane Inhalation Using a Disposable Delivery System (AnaConDa©) in Obese ICU Patients

Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
Describing a pharmacokinetic model of 48-h sevoflurane sedation in obese ICU patients
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital, Clermont-Ferrand
Treatments:
Sevoflurane